Download the new Dimensions White Paper to discover the current and emerging research trends in Pharma.
In this podcast, MAPS speaks with experts from Pfizer and Putnam Associates about the most exciting current uses of AI and also where we may be headed in the future.
Danie du Plessis, Chair of the MAPS Board of Directors, speaks with HSTalks about the MAPS organization and Medical Affairs leadership.
This White Paper ranks social media platforms, demonstrates how life science companies are adapting to the digital world, defines the digital opinion leader and how to find one, and provides 4 key takeaways that you can start implementing right away.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
In this webinar, our panelists highlight key areas of the Standards and Guidance created between MAPS, phactMI & MILE and how to use this S&G to move to a best-in-class medical information organization.
“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
In this on-demand webinar, our experts provide guidance and potential solutions on addressing major barriers for patient centricity initiatives identified through their survey.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.